MethylGene Inc. Report issue

For profit Phase 1 Phase 2
Founded: Montreal Canada (1997)
Status: Acquired by Mirati Therapeutics Inc. (2013)

Organization Overview

First Clinical Trial
2004
NCT00323934
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree